Back to User profile » Professor Xiaofeng Chen

Papers published by Professor Xiaofeng Chen:

Study Protocol

Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial

Wang KX, Cui TY, Yang XD, Wang GQ, Jiang QS, Sun H, Jiang NY, Yong XM, Shi CB, Ding YB, Chen XF, Fang YY

OncoTargets and Therapy 2021, 14:4859-4865

Published Date: 21 September 2021

Review

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer

Seesaha PK, Wang KX, Wang GQ, Cui TY, Zhao FJ, Pan LL, Li XC, Shu YQ, Chen XF

OncoTargets and Therapy 2021, 14:1873-1882

Published Date: 12 March 2021

Original Research

Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival

Ma L, Qiu JR, Zhang YD, Qiu TZ, Wang B, Chen WS, Li X, Sun J, Wang K, Li XC, Gu YH, Shu YQ, Chen XF

OncoTargets and Therapy 2018, 11:2533-2543

Published Date: 4 May 2018

Review

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer

Qiu TZ, Chen WS, Li P, Sun J, Gu YH, Chen XF

OncoTargets and Therapy 2018, 11:465-471

Published Date: 22 January 2018